Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.



This is a "connection" page, showing publications co-authored by Jennifer Trujillo and Sarah Anderson.

Connection Strength
  1. Anderson SL, Beutel TR, Trujillo JM. Oral semaglutide in type 2 diabetes. J Diabetes Complications. 2020 04; 34(4):107520.
    View in: PubMed
    Score: 0.889
  2. Anderson SL, Trujillo JM. Basal Insulin Use With GLP-1 Receptor Agonists. Diabetes Spectr. 2016 Aug; 29(3):152-60.
    View in: PubMed
    Score: 0.701
  3. Anderson SL, Trujillo JM. Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness. Ther Adv Chronic Dis. 2016 Jan; 7(1):4-17.
    View in: PubMed
    Score: 0.673
  4. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010 May; 44(5):904-9.
    View in: PubMed
    Score: 0.452
  5. Anderson SL, Trujillo JM, Anderson JE, Tanenberg RJ. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgrad Med. 2018 Mar; 130(2):229-238.
    View in: PubMed
    Score: 0.193
  6. Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71.
    View in: PubMed
    Score: 0.132
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)